| Literature DB >> 35028228 |
Vidyashree Hulkoti1, Sandeep Kamat2, Sourya Acharya1, Samarth Shukla3, Sunil Kumar1, Dhruv Talwar1.
Abstract
Pulmonary embolism is linked with a remarkable rate of mortality, particularly when it is associated with hemodynamic instability, right atrial thrombus and related right ventricular dysfunction. In patients affected with pulmonary embolism, thrombolysis has been documented to be life-saving. The administration of thrombolytic agents ensures early resolution of the thrombus and prevents arrhythmia and cardiogenic shock. Streptokinase, urokinase and alteplase are among the three thrombolytic agents approved for the treatment of pulmonary embolism. In emergency situations, thrombectomy plays a crucial role.Entities:
Keywords: deep vein thrombosis; heparin; pulmonary embolism; serpentine clot; virchow s triad
Year: 2021 PMID: 35028228 PMCID: PMC8743344 DOI: 10.7759/cureus.20336
Source DB: PubMed Journal: Cureus ISSN: 2168-8184